Kanes Stephen

CIK 00016128592 companiesCHESHIRE

SEC Profile

Transactions

Companies

Filings

CIK

0001612859

Recent Transactions

50 trades

Disposition to Issuer
Centessa Pharmaceuticals plc$CNTA
Ordinary Shares
2026-06-24−120,000→ 0 total
Disposition to Issuer
Centessa Pharmaceuticals plc$CNTA
Share Option (right to buy)
2026-06-24−500,000→ 0 total
Award
Centessa Pharmaceuticals plc$CNTA
Ordinary Shares
2026-02-02+120,000→ 120,000 total
Award
Centessa Pharmaceuticals plc$CNTA
Share Option (right to buy)
2025-02-03+500,000→ 500,000 total
Tax Payment
Sage Therapeutics, Inc.
Common Stock
2021-10-19$40.29/sh−1,120→ 13,471 total
Award
Sage Therapeutics, Inc.
Common Stock
2021-10-19+3,800→ 14,591 total
Tax Payment
Sage Therapeutics, Inc.
Common Stock
2021-06-15$58.80/sh−1,001→ 10,791 total
Award
Sage Therapeutics, Inc.
Common Stock
2021-06-15+3,500→ 11,792 total
Award
Sage Therapeutics, Inc.
Stock Option (Right to Buy)
2021-02-10+19,000→ 19,000 total
Award
Sage Therapeutics, Inc.
Stock Option (Right to Buy)
2020-04-28+9,450→ 9,450 total
Award
Sage Therapeutics, Inc.
Stock Option (Right to Buy)
2020-02-12+17,500→ 17,500 total
Exercise/Conversion
Sage Therapeutics, Inc.
Stock Option (Right to Buy)
2019-09-04−6,000→ 86,100 total
Exercise/Conversion
Sage Therapeutics, Inc.
Common Stock
2019-09-04$0.45/sh+6,000→ 8,292 total
Tax Payment
Sage Therapeutics, Inc.
Common Stock
2019-07-25$161.38/sh−549→ 2,292 total
Award
Sage Therapeutics, Inc.
Common Stock
2019-07-25+1,900→ 2,841 total
Award
Sage Therapeutics, Inc.
Stock Option (Right to Buy)
2019-06-21+6,600→ 13,200 total
Award
Sage Therapeutics, Inc.
Stock Option (Right to Buy)
2019-02-13+19,000→ 19,000 total
Sale
Sage Therapeutics, Inc.
Common Stock
2019-02-08$150.00/sh−22,948→ 941 total
Award
Sage Therapeutics, Inc.
Stock Option (Right to Buy)
2018-12-07+6,600→ 6,600 total
Award
Sage Therapeutics, Inc.
Stock Option (Right to Buy)
2018-04-02+27,000→ 27,000 total
Award
Sage Therapeutics, Inc.
Stock Option (Right to Buy)
2017-02-06+40,000→ 40,000 total
Award
Sage Therapeutics, Inc.
Stock Option (Right to Buy)
2016-12-08+14,400→ 68,000 total
Exercise/Conversion
Sage Therapeutics, Inc.
Stock Option (Right to Buy)
2016-04-20−21,000→ 112,100 total
Exercise/Conversion
Sage Therapeutics, Inc.
Common Stock
2016-04-20$0.45/sh+21,000→ 46,948 total
Sale
Sage Therapeutics, Inc.
Common Stock
2016-04-19$38.00/sh−21,000→ 25,948 total
Award
Sage Therapeutics, Inc.
Stock Option (Right to Buy)
2016-02-08+20,000→ 20,000 total
Exercise/Conversion
Sage Therapeutics, Inc.
Stock Option (Right to Buy)
2015-09-28−21,000→ 133,100 total
Sale
Sage Therapeutics, Inc.
Common Stock
2015-09-28$46.42/sh−6,000→ 46,948 total
Exercise/Conversion
Sage Therapeutics, Inc.
Common Stock
2015-09-28$0.45/sh+21,000→ 52,948 total
Sale
Sage Therapeutics, Inc.
Common Stock
2015-08-31$53.12/sh−12,000→ 31,948 total
Exercise/Conversion
Sage Therapeutics, Inc.
Common Stock
2015-07-27$0.45/sh+1,936→ 48,884 total
Sale
Sage Therapeutics, Inc.
Common Stock
2015-07-27$69.38/sh−800→ 47,584 total
Exercise/Conversion
Sage Therapeutics, Inc.
Stock Option (Right to Buy)
2015-07-27−1,936→ 154,100 total
Sale
Sage Therapeutics, Inc.
Common Stock
2015-07-27$69.60/sh−900→ 44,602 total
Sale
Sage Therapeutics, Inc.
Common Stock
2015-07-27$68.50/sh−636→ 46,948 total
Sale
Sage Therapeutics, Inc.
Common Stock
2015-07-27$72.08/sh−826→ 45,902 total
Sale
Sage Therapeutics, Inc.
Common Stock
2015-07-27$68.67/sh−654→ 43,948 total
Sale
Sage Therapeutics, Inc.
Common Stock
2015-07-27$72.00/sh−500→ 48,384 total
Sale
Sage Therapeutics, Inc.
Common Stock
2015-07-27$70.91/sh−400→ 45,502 total
Sale
Sage Therapeutics, Inc.
Common Stock
2015-07-27$73.64/sh−220→ 46,728 total
Exercise/Conversion
Sage Therapeutics, Inc.
Stock Option (Right to Buy)
2015-06-24−6,000→ 40,300 total
Sale
Sage Therapeutics, Inc.
Common Stock
2015-06-24$74.06/sh−6,000→ 46,948 total
Exercise/Conversion
Sage Therapeutics, Inc.
Common Stock
2015-06-24$0.45/sh+6,000→ 52,948 total
Sale
Sage Therapeutics, Inc.
Common Stock
2015-03-25$51.49/sh−5,400→ 46,948 total
Sale
Sage Therapeutics, Inc.
Common Stock
2015-02-25$42.05/sh−6,000→ 52,348 total
Sale
Sage Therapeutics, Inc.
Common Stock
2015-01-26$37.29/sh−6,000→ 58,348 total
Award
Sage Therapeutics, Inc.
Stock Option (Right to Buy)
2015-01-23+68,000→ 68,000 total
Exercise/Conversion
Sage Therapeutics, Inc.
Common Stock
2014-08-28$0.45/sh+60,186→ 63,186 total
Exercise/Conversion
Sage Therapeutics, Inc.
Common Stock
2014-08-28$1.36/sh+1,162→ 64,348 total
Exercise/Conversion
Sage Therapeutics, Inc.
Stock Option (right to buy)
2014-08-28−60,186→ 162,036 total

Companies

Recent Filings

Address

C/O CENTESSA PHARMACEUTICALS PLC 3RD FL., 1 ASHLEY RD, ALTRINCHAM

CHESHIRE, WA14 2DT

View on SEC.gov